ABO-Incompatible and human leukocyte antigen-incompatible kidney transplant in a highly sensitized patient with hepatitis-B

被引:0
作者
Bavikar, Suhas [1 ]
Ganjewar, Vaibhav [2 ]
Oswal, Ajay [3 ]
Bavikar, Purva [1 ,4 ]
机构
[1] MIT Hosp, Dept Nephrol, Aurangabad, Maharashtra, India
[2] GI One Hosp, Dept Gastroenterol, Inst Gastroenterol, Aurangabad, Maharashtra, India
[3] Seth Nandlal Dhoot Hosp, Dept Urol, Aurangabad, Maharashtra, India
[4] 108 Utkarsh Hosp,Adalat Rd, Aurangabad, Maharashtra, India
关键词
ABO incompatible; chronic viral hepatitis B in kidney transplantation; human leukocyte antigen incompatible; MANAGEMENT;
D O I
10.4103/ijot.ijot_6_23
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
A 40-year-old female of Indian origin underwent spousal donor ABO-incompatible (ABOi) kidney transplantation. She was diagnosed to have end-stage kidney disease, around 1 year before transplant and it was presumed to be chronic tubulointerstitial nephritis. The female was detected to have acute hepatitis B, 2 months before transplant. She was a highly-sensitized patient with a prior history of blood transfusion and multiparity. Single-antigen bead assay was positive pretransplant. The removal of anti-human leukocyte antigen donor-specific antibodies and anti-B antibodies in our patient was a multi-step process. Timely initiation of antiviral therapy is crucial to reduce viral load and make the patient fit for transplantation. Despite a multitude of risk factors, our patient underwent successful kidney transplantation with a baseline creatinine of 0.6 mg/dL and excellent graft function.
引用
收藏
页码:245 / 248
页数:4
相关论文
共 7 条
  • [1] Chadban SJ, 2020, TRANSPLANTATION, V104, pS11, DOI 10.1097/TP.0000000000003136
  • [2] Recent US Food and Drug Administration Warnings on Hepatitis B Reactivation With Immune-Suppressing and Anticancer Drugs: Just the Tip of the Iceberg?
    Di Bisceglie, Adrian M.
    Lok, Anna S.
    Martin, Paul
    Terrault, Norah
    Perrillo, Robert P.
    Hoofnagle, Jay H.
    [J]. HEPATOLOGY, 2015, 61 (02) : 703 - 711
  • [3] Drug Interactions, 2023, LEXICOMP DRUG INTERA
  • [4] Management of Antiviral Resistance in Chronic Hepatitis B
    Lim, Young-Suk
    [J]. GUT AND LIVER, 2017, 11 (02) : 189 - 195
  • [5] Outcome after kidney transplantation in hepatitis B surface antigen-positive patients
    Mo, Hyejin
    Min, Sangil
    Han, Ahram
    Jung, In Mok
    Ha, Jongwon
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] THE IMPACT OF RENAL-TRANSPLANTATION ON THE COURSE OF HEPATITIS-B LIVER-DISEASE
    PARFREY, PS
    FORBES, RDC
    HUTCHINSON, TA
    KENICK, S
    FARGE, D
    DAUPHINEE, WD
    SEELY, JF
    GUTTMANN, RD
    [J]. TRANSPLANTATION, 1985, 39 (06) : 610 - 615
  • [7] LONG-TERM EFFECT OF HBS ANTIGENEMIA ON PATIENT SURVIVAL AFTER RENAL-TRANSPLANTATION
    PIRSON, Y
    ALEXANDRE, GPJ
    VANYPERSELEDESTRIHOU, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (04) : 194 - 196